These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26591160)

  • 21. Drug induced pericarditis in a patient with chronic renal failure.
    Bozkurt A; Paydaş S
    Ren Fail; 2002 Sep; 24(5):667-70. PubMed ID: 12380914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenal crisis during anti-tuberculosis treatment.
    Guglielmetti L; Conti M; Grigolo C; Cazzadori A; Concia E
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):929-30. PubMed ID: 20550784
    [No Abstract]   [Full Text] [Related]  

  • 23. Paradoxical response to anti-tuberculous therapy presenting as choroiditis.
    Goel N
    Clin Exp Optom; 2015 Mar; 98(2):183-5. PubMed ID: 25727942
    [No Abstract]   [Full Text] [Related]  

  • 24. [Side effects of antitubercular preparations and their diagnosis in children by Schelley's test].
    Elufimova VF; Mitinskaia LA; Vasil'eva AM; Koviazina AI
    Probl Tuberk; 1985; (10):55-9. PubMed ID: 3877930
    [No Abstract]   [Full Text] [Related]  

  • 25. A case of hyperacute hepatotoxicity in response to tuberculosis therapy.
    Hercus CG; Khoo JK; Jones TE
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1709-10. PubMed ID: 23131275
    [No Abstract]   [Full Text] [Related]  

  • 26. Postprandial serum cholylglycine as a marker of antituberculous drug hepatotoxicity in HIV-infected patients.
    Alegre J; Fernandez de Sevilla T; Falcó V; Armadans L; Martínez Vázquez JM
    Chest; 1993 Oct; 104(4):1312-3. PubMed ID: 8404228
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatic function monitoring during tuberculotherapy (author's transl)].
    Pageaux JF; Duperray B; Dubois M; Pacheco H; Pacheco Y; Brun J; Perrin-Fayolle M; Kofman J
    Therapie; 1979; 34(4):505-13. PubMed ID: 531782
    [No Abstract]   [Full Text] [Related]  

  • 28. Paradoxical reaction during tuberculosis treatment in HIV-seronegative patients.
    Carvalho AC; De Iaco G; Saleri N; Pini A; Capone S; Manfrin M; Matteelli A
    Clin Infect Dis; 2006 Mar; 42(6):893-5. PubMed ID: 16477577
    [No Abstract]   [Full Text] [Related]  

  • 29. Isoniazid-associated hepatitis in a Melanesian.
    Britton WJ
    P N G Med J; 1977 Dec; 20(4):198-202. PubMed ID: 277000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Monitoring of antitubercular treatments. Value of the determination of serum gamma-glutamyl transpeptidase (gamma-GT)].
    Homasson JP; Salignac P; Bonniot JP; Parent G; Angebault M
    Nouv Presse Med; 1977 Mar; 6(10):858. PubMed ID: 15237
    [No Abstract]   [Full Text] [Related]  

  • 31. Prophylaxis of anaphylactoid reaction to antituberculous drugs.
    Kévorkian JP; Seroux C; Deharbe S; Salord JM; Bergmann JF
    Ann Pharmacother; 1997 Mar; 31(3):373-4. PubMed ID: 9066953
    [No Abstract]   [Full Text] [Related]  

  • 32. Rifampin plus pyrazinamide-induced hepatitis requiring hospitalization in a 30-y-old male with latent tuberculosis.
    Potolidis E; Mantadakis E; Zeniodi MH; Samonis G
    Scand J Infect Dis; 2005; 37(2):155-7. PubMed ID: 15773037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinic and pathogenesis of drug hepatitis].
    Mardare G
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(1):43-5. PubMed ID: 25591247
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply to Sharma et Al and Saukkonen et Al.
    Heller T; Wallrauch C; Lessells RJ
    Clin Infect Dis; 2010 Jul; 51(2):255. PubMed ID: 20560741
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of the successful treatment of drug-induced toxic hepatitis in a child with tuberculous meningoencephalitis].
    Kalugin AV; Kolesnikova IV; Zhuravleva LIu; Churiumova OG; Maĭorov VM
    Anesteziol Reanimatol; 1998; (1):68-9. PubMed ID: 9553268
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tuberculostatics in caseating lymph node tuberculosis].
    Jentgens H
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1172-3. PubMed ID: 976108
    [No Abstract]   [Full Text] [Related]  

  • 37. [Management of primary hilus lymph node tuberculosis in children].
    van Zeben W
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 137(2):144-7. PubMed ID: 5311697
    [No Abstract]   [Full Text] [Related]  

  • 38. Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?
    Jasmer RM; Daley CL
    Am J Respir Crit Care Med; 2003 Mar; 167(6):809-10. PubMed ID: 12623855
    [No Abstract]   [Full Text] [Related]  

  • 39. [Differential diagnosis of chronic non-viral hepatitis].
    Eisenburg J
    Fortschr Med; 1985 Feb; 103(7):133-43. PubMed ID: 3871723
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.